• 1. Alt-proteins: A promising future
• 2. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 3. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 4. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 5. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenols 1-hydroxy-2-unsubstituted benzenoids

Phenol, 4-(3-bromopropyl)- (CAS No. 52273-55-9): A Comprehensive Overview

Phenol, 4-(3-bromopropyl)-, identified by the chemical compound code CAS No. 52273-55-9, is a significant intermediate in the realm of organic synthesis and pharmaceutical research. This compound, characterized by its unique structural motif, has garnered considerable attention due to its versatile applications in the development of novel therapeutic agents and specialty chemicals. The presence of both a phenolic group and a brominated alkyl chain imparts distinct reactivity and functional properties, making it a valuable building block in synthetic chemistry.

The molecular structure of Phenol, 4-(3-bromopropyl)- consists of a benzene ring substituted with a hydroxyl group at the para position relative to a bromopropyl side chain. This configuration allows for a range of chemical transformations, including nucleophilic aromatic substitution, cross-coupling reactions, and etherification processes. Such reactivity is leveraged in pharmaceutical synthesis to construct complex molecular architectures essential for drug discovery and development.

In recent years, the compound has found utility in the synthesis of bioactive molecules targeting various therapeutic areas. For instance, derivatives of this scaffold have been explored as potential inhibitors of enzymes involved in inflammatory pathways. The bromine atom serves as a handle for further functionalization, enabling the attachment of pharmacophores that enhance binding affinity and selectivity. This has led to its incorporation into libraries of compounds screened for biological activity.

Moreover, the compound's role in material science has not been overlooked. Its ability to form polymers or copolymers with other monomers has been investigated for applications in coatings and adhesives. The phenolic group contributes to hydrogen bonding interactions, while the bromopropyl chain provides hydrophobicity, resulting in materials with tailored physical properties. Such applications underscore the compound's versatility beyond traditional pharmaceuticals.

The synthesis of Phenol, 4-(3-bromopropyl)- typically involves the bromination of propylbenzene followed by selective hydroxylation. Advances in catalytic methods have improved the efficiency and yield of these reactions, making large-scale production more feasible. Recent studies have focused on greener methodologies, employing biocatalysts or photochemical activation to minimize waste and energy consumption. These innovations align with broader efforts to sustainable chemical manufacturing.

In the context of drug discovery, the compound serves as a precursor for more complex molecules with enhanced pharmacological profiles. For example, researchers have utilized it to synthesize analogs of nonsteroidal anti-inflammatory drugs (NSAIDs), where modifications at the phenolic and brominated positions modulate efficacy and toxicity. Such work highlights its importance as a key intermediate in medicinal chemistry.

The analytical characterization of Phenol, 4-(3-bromopropyl)- relies on advanced spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). These methods provide detailed insights into its molecular structure and purity, which are critical for pharmaceutical applications where impurities can affect therapeutic outcomes. High-performance liquid chromatography (HPLC) is also employed for purification and quantification purposes.

The safety profile of this compound is another area of interest. While it is not classified as hazardous under standard conditions, proper handling procedures are recommended due to its potential reactivity with strong oxidizing agents. Industrial applications necessitate controlled environments to prevent unintended side reactions that could compromise product integrity.

Future research directions may explore novel derivatives of this scaffold with improved pharmacokinetic properties or enhanced bioavailability. Computational modeling techniques are increasingly being used to predict how structural modifications will influence biological activity, reducing the need for extensive experimental screening. This integration of computational chemistry with synthetic organic chemistry accelerates the drug discovery process.

The economic significance of Phenol, 4-(3-bromopropyl)- cannot be overstated. As demand for specialized intermediates grows, so does the market for high-quality suppliers capable of producing consistent batches meeting stringent specifications. Companies investing in process optimization and quality control are well-positioned to meet this demand while adhering to regulatory standards。

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)